Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 374

1.

Alpha-glucosidase inhibitor use is associated with decreased colorectal neoplasia risk in patients with type 2 diabetes mellitus receiving colonoscopy: a retrospective study.

Horibe Y, Adachi S, Ohno T, Goto N, Okuno M, Iwama M, Yamauchi O, Kojima T, Saito K, Ibuka T, Yasuda I, Araki H, Moriwaki H, Shimizu M.

Oncotarget. 2017 Jun 8. doi: 10.18632/oncotarget.18416. [Epub ahead of print]

2.

Genetic Recombination Between Stromal and Cancer Cells Results in Highly Malignant Cells Identified by Color-Coded Imaging in a Mouse Lymphoma Model.

Nakamura M, Suetsugu A, Hasegawa K, Matsumoto T, Aoki H, Kunisada T, Shimizu M, Saji S, Moriwaki H, Hoffman RM.

J Cell Biochem. 2017 Apr 17. doi: 10.1002/jcb.26068. [Epub ahead of print]

PMID:
28419513
3.

Sarcopenia predicts minimal hepatic encephalopathy in patients with liver cirrhosis.

Hanai T, Shiraki M, Watanabe S, Kochi T, Imai K, Suetsugu A, Takai K, Moriwaki H, Shimizu M.

Hepatol Res. 2017 Feb 15. doi: 10.1111/hepr.12873. [Epub ahead of print]

PMID:
28199774
4.

Color-coded Imaging Enables Fluorescence-guided Surgery to Resect the Tumor Along with the Tumor Microenvironment in a Syngeneic Mouse Model of EL-4 Lymphoma.

Hasegawa K, Suetsugu A, Nakamura M, Matsumoto T, Kunisada T, Shimizu M, Saji S, Moriwaki H, Bouvet M, Hoffman RM.

Anticancer Res. 2016 Sep;36(9):4443-8.

PMID:
27630280
5.

The Deficiency of Indoleamine 2,3-Dioxygenase Aggravates the CCl4-Induced Liver Fibrosis in Mice.

Ogiso H, Ito H, Ando T, Arioka Y, Kanbe A, Ando K, Ishikawa T, Saito K, Hara A, Moriwaki H, Shimizu M, Seishima M.

PLoS One. 2016 Sep 6;11(9):e0162183. doi: 10.1371/journal.pone.0162183. eCollection 2016.

6.

Color-coded Live Imaging of Heterokaryon Formation and Nuclear Fusion of Hybridizing Cancer Cells.

Suetsugu A, Matsumoto T, Hasegawa K, Nakamura M, Kunisada T, Shimizu M, Saji S, Moriwaki H, Bouvet M, Hoffman RM.

Anticancer Res. 2016 Aug;36(8):3827-31.

PMID:
27466484
7.

Anticancer effect of arsenite on cell migration, cell cycle and apoptosis in human pancreatic cancer cells.

Horibe Y, Adachi S, Yasuda I, Yamauchi T, Kawaguchi J, Kozawa O, Shimizu M, Moriwaki H.

Oncol Lett. 2016 Jul;12(1):177-182. Epub 2016 May 13.

8.

Serum concentrations of l-kynurenine predict clinical outcomes of patients with peripheral T-cell lymphoma, not otherwise specified.

Shibata Y, Hara T, Matsumoto T, Nakamura N, Nakamura H, Ninomiya S, Kitagawa J, Goto N, Nannya Y, Ito H, Kito Y, Miyazaki T, Takeuchi T, Saito K, Seishima M, Takami T, Moriwaki H, Shimizu M, Tsurumi H.

Hematol Oncol. 2016 Jun 24. doi: 10.1002/hon.2318. [Epub ahead of print]

PMID:
27338762
9.

Development of a Novel Scoring System for Predicting the Risk of Colorectal Neoplasia: A Retrospective Study.

Ohno T, Adachi S, Okuno M, Horibe Y, Goto N, Iwama M, Yamauchi O, Kojima T, Saito K, Ibuka T, Yasuda I, Araki H, Moriwaki H, Shimizu M.

PLoS One. 2016 Jun 10;11(6):e0157269. doi: 10.1371/journal.pone.0157269. eCollection 2016.

10.

Carnitine dynamics and their effects on hyperammonemia in cirrhotic Japanese patients.

Shiraki M, Shimizu M, Moriwaki H, Okita K, Koike K.

Hepatol Res. 2017 Mar;47(4):321-327. doi: 10.1111/hepr.12750. Epub 2016 Aug 2.

PMID:
27254133
11.

Evidence-based clinical practice guidelines for liver cirrhosis 2015.

Fukui H, Saito H, Ueno Y, Uto H, Obara K, Sakaida I, Shibuya A, Seike M, Nagoshi S, Segawa M, Tsubouchi H, Moriwaki H, Kato A, Hashimoto E, Michitaka K, Murawaki T, Sugano K, Watanabe M, Shimosegawa T.

J Gastroenterol. 2016 Jul;51(7):629-50. doi: 10.1007/s00535-016-1216-y. Epub 2016 May 31. Review.

PMID:
27246107
12.

A salvage chemotherapy of R-P-IMVP16/CBDCA consisting of rituximab, methylprednisolone, ifosfamide, methotrexate, etoposide, and carboplatin for patients with diffuse large B cell lymphoma who had previously received R-CHOP therapy as first-line chemotherapy.

Matsumoto T, Hara T, Shibata Y, Nakamura N, Nakamura H, Ninomiya S, Kitagawa J, Kanemura N, Goto N, Kito Y, Kasahara S, Yamada T, Sawada M, Miyazaki T, Takami T, Takeuchi T, Moriwaki H, Tsurumi H.

Hematol Oncol. 2016 Mar 21. doi: 10.1002/hon.2285. [Epub ahead of print]

PMID:
26999778
13.

Cimetidine and Clobenpropit Attenuate Inflammation-Associated Colorectal Carcinogenesis in Male ICR Mice.

Tanaka T, Kochi T, Shirakami Y, Mori T, Kurata A, Watanabe N, Moriwaki H, Shimizu M.

Cancers (Basel). 2016 Feb 20;8(2). pii: E25. doi: 10.3390/cancers8020025.

14.

The significance of phosphorylated heat shock protein 27 on the prognosis of pancreatic cancer.

Okuno M, Yasuda I, Adachi S, Nakashima M, Kawaguchi J, Doi S, Iwashita T, Hirose Y, Kozawa O, Yoshimi N, Shimizu M, Moriwaki H.

Oncotarget. 2016 Mar 22;7(12):14291-9. doi: 10.18632/oncotarget.7424.

15.

Sodium alginate prevents progression of non-alcoholic steatohepatitis and liver carcinogenesis in obese and diabetic mice.

Miyazaki T, Shirakami Y, Kubota M, Ideta T, Kochi T, Sakai H, Tanaka T, Moriwaki H, Shimizu M.

Oncotarget. 2016 Mar 1;7(9):10448-58. doi: 10.18632/oncotarget.7249.

16.

Metabolome Analyses Uncovered a Novel Inhibitory Effect of Acyclic Retinoid on Aberrant Lipogenesis in a Mouse Diethylnitrosamine-Induced Hepatic Tumorigenesis Model.

Qin XY, Tatsukawa H, Hitomi K, Shirakami Y, Ishibashi N, Shimizu M, Moriwaki H, Kojima S.

Cancer Prev Res (Phila). 2016 Mar;9(3):205-14. doi: 10.1158/1940-6207.CAPR-15-0326. Epub 2016 Jan 7.

17.

The Role of Indoleamine 2,3-Dioxygenase in Diethylnitrosamine-Induced Liver Carcinogenesis.

Shibata Y, Hara T, Nagano J, Nakamura N, Ohno T, Ninomiya S, Ito H, Tanaka T, Saito K, Seishima M, Shimizu M, Moriwaki H, Tsurumi H.

PLoS One. 2016 Jan 4;11(1):e0146279. doi: 10.1371/journal.pone.0146279. eCollection 2016.

18.

The Dipeptidyl Peptidase-4 Inhibitor Teneligliptin Attenuates Hepatic Lipogenesis via AMPK Activation in Non-Alcoholic Fatty Liver Disease Model Mice.

Ideta T, Shirakami Y, Miyazaki T, Kochi T, Sakai H, Moriwaki H, Shimizu M.

Int J Mol Sci. 2015 Dec 8;16(12):29207-18. doi: 10.3390/ijms161226156.

19.

Revised criteria for classification of the etiologies of acute liver failure and late-onset hepatic failure in Japan: A report by the Intractable Hepato-biliary Diseases Study Group of Japan in 2015.

Mochida S, Nakayama N, Ido A, Takikawa Y, Yokosuka O, Sakaida I, Moriwaki H, Genda T, Takikawa H.

Hepatol Res. 2016 Mar;46(5):369-71. doi: 10.1111/hepr.12626. Epub 2016 Jan 19.

PMID:
26615003
20.

Rapid skeletal muscle wasting predicts worse survival in patients with liver cirrhosis.

Hanai T, Shiraki M, Ohnishi S, Miyazaki T, Ideta T, Kochi T, Imai K, Suetsugu A, Takai K, Moriwaki H, Shimizu M.

Hepatol Res. 2016 Jul;46(8):743-51. doi: 10.1111/hepr.12616. Epub 2016 Jan 28.

PMID:
26579878

Supplemental Content

Loading ...
Support Center